Next 10 |
2024-04-24 09:19:50 ET More on Moderna Moderna Investors Should Beware Patent-Dispute Fallout Moderna: Considering The Cancer Vaccine Angle Moderna Continues To Build A Pipeline S&P 500 stocks with biggest estimated EPS declines for Q1 Moderna sto...
2024-04-16 17:02:18 ET Gainers: United Airlines Holdings ( UAL ) +6% . American Airlines Group ( AAL ) +2% . Enphase Energy ( ENPH ) +2% . Absci Corporation ( ABSI ) +1% . Ocular Therapeutix ( OCUL ) +1% . Losers: J.B. Hu...
VANCOUVER, Wash. and NEW YORK, April 16, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will report business updates and financial and operating results for the first quarter before market open on Tuesday, M...
2024-04-07 17:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-03-28 23:02:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
VANCOUVER, Wash. and NEW YORK, March 28, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will be participating in the upcoming 23 rd Annual Needham Virtual Healthcare Conference. Absci management is...
2024-03-22 16:15:03 ET Scotiabank analyst issues SECTOR OUTPERFORM recommendation for ABSI on March 22, 2024 03:00PM ET. The previous analyst recommendation was Sector Outperform. ABSI was trading at $4.905 at issue of the analyst recommendation. The overall analyst cons...
2024-03-21 11:27:23 ET More on Absci Absci: Differentiated Antibody Discovery Play Absci prices $75M equity offering at $4.50 per share Read the full article on Seeking Alpha For further details see: Absci GAAP EPS of -$0.25 misses by $0.01, revenue of $0...
Initiated IND-enabling studies for ABS-101, a potential best-in-class anti-TL1A antibody Entered into collaboration with AstraZeneca for up to $247M in deal value, plus royalties Strengthened balance sheet raising approximately $86M in gross proceeds through underwritten common ...
2024-03-06 08:45:57 ET More on Mid-day gainers & stocks. Dada Nexus Rides Closer To JD.com's Orbit With Management Shakeup Infobird to effect 1-for-8 reverse stock split to regain compliance with Nasdaq rules NIO, Dada Nexus and Luckin Coffee lead strong recovery...
News, Short Squeeze, Breakout and More Instantly...
Absci Corporation Company Name:
ABSI Stock Symbol:
NASDAQ Market:
VANCOUVER, Wash. and NEW YORK, April 16, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will report business updates and financial and operating results for the first quarter before market open on Tuesday, M...
U.S. stocks were lower, with the Dow Jones index falling over 200 points on Tuesday. Shares of BlackBerry Limited (NYSE: BB) rose sharply during T...
2024-04-07 17:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...